Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid-Reference-Cited by-同舟云学术

Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid

Author:

Savvides Panayiotis¹²,Nagaiah Govardhanan³,Lavertu Pierre¹²,Fu Pingfu¹²,Wright John J.⁴,Chapman Robert⁵,Wasman Jay¹²,Dowlati Afshin¹²,Remick Scot C.³

Affiliation:

1. Division of Hematology/Oncology, Seidman Cancer Center, University Hospitals, Cleveland, Ohio.

2. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.

3. Division of Hematology/Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia.

4. Cancer Therapy and Evaluation Program, National Cancer Institute, Bethesda, Maryland.

5. Division of Hematology/Oncology, Henry Ford Hospital Health System, Detroit, Michigan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference19 articles.

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献